Publications by authors named "Nehal Nailesh Mehta"
Purpose: This study evaluates how accurately humans and artificial intelligence (AI) can identify the type of surgery performed for epiretinal membrane (ERM) removal by analyzing postoperative optical coherence tomography (OCT) scans.
Methods: A retrospective analysis at the University of California San Diego included 250 eyes from 239 patients who underwent vitrectomy for idiopathic ERM between January 2013 and October 2024. Eyes were categorized into two groups: one with both the internal limiting membrane (ILM) and ERM removed using indocyanine green (ICG) staining, and another with only ERM removal, guided by triamcinolone.
Background: To analyze the therapeutic response to faricimab 6 mg/0.05 ml in eyes with neovascular AMD (nAMD) with refractory intra- and/or subretinal fluid due to choroidal neovascularization (CNV), previously unresponsive to 4 mg monthly aflibercept and combination therapy with anti-VEGF and long-acting steroids.
Methods: A retrospective case series study of 22 eyes with unresponsive CNV, despite monthly intravitreal treatment (mean number of pre-faricimab injections: 35.
Aims: To determine the effect of continuing anti-vascular endothelial growth factor (VEGF) injections on the progression of macular atrophy (MA) during remission of neovascular age-related macular degeneration (nAMD).
Methods: In this retrospective cohort study, 59 eyes with nAMD with at least 6-month remission (disease inactivity) were analysed and were grouped into two. In group 1, anti-VEGF injections were stopped after remission (holiday).
Purpose: To determine the impact of severity of age-related macular degeneration (AMD) on subjective treatment response in patients treated for dry eye disease.
Methods: A total of 203 eyes diagnosed with evaporative dry eye disease (DED) due to meibomian gland dysfunction were treated using the LipiFlow or MiBoFlo systems. From this cohort, 40 eyes with stable dry AMD (early, intermediate, or late stages) were included.